About 8.9 percent of adults in Malawi are HIV positive, especially women and young people. Blantyre and its rural surroundings are among the areas with the highest prevalence of HIV in Malawi, with an HIV prevalence of 13.2 percent. 21 percent of people living with HIV are not receiving life-saving AIDS treatment (ART). ART and other assistance led to fewer new HIV infections and mortality.
Five HIV centres in Blantyre and the surrounding area are improving their medical and community-based services on HIV/AIDS (especially for women and children), cervical cancer and non-communicable diseases.
Indicators are training, awareness campaigns in urban and rural areas and the establishment of support groups.
Basic services provided by the five HIV centres:
- Rapid HIV tests and counselling sessions
- Diagnosis and treatment of infections including HIV therapy (ART), opportunistic infections and measures to protect against SARS-CoV-2
- Prevention of mother-to-child transmission of HIV (PMTCT)
Maternal and child health services:
- Maternal and child health training for expert clients and health workers
- Measures to maintain adequate adherence and retention: implementation of support groups for "Women in PMTCT" and "Young mothers".
Screening and treatment of cervical cancer:
- Training on cervical cancer screening and treatment
- Awareness-raising and screening campaigns for cervical cancer
- Screening and treatment of cervical cancer
Treatment of non-communicable diseases (NCDs):
- Training on non-communicable diseases (NCDs)
- Awareness campaigns for epilepsy
- Diagnosis and treatment of non-communicable diseases (NCDs) ,especially epilepsy, hypertension, diabetes
The perspectives of the project are that the activities will be implemented in public institutions in the sense of capacity building and will be presented to other public health centres as a model through extensive cooperation and advocacy.
Innovations include expanding community-based activities and awareness campaigns and treatment of epilepsy and cervical cancer.